Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-044656

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Gad Soffer
Officer — Chief Operating Officer
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 15, 2015M22,111$0.00A34,511D
Common StockF1May 15, 2015M80,128$0.00A114,639D
Common StockMay 15, 2015F48,851$37.30D65,788D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF2,F3,F4—May 15, 2015A80,128A——Common Stock80,12873,718D
Restricted Stock UnitsF2,F5,F6—May 15, 2015A22,111A——Common Stock22,11144,221D

Explanation of responses